Asynchronies of diphenhydramine plasma-performance relationships

Pharmacology, Biochemistry, and Behavior
V LickoG Barnett

Abstract

The relation between performance on driving-related tasks and plasma levels of diphenhydramine was studied in eight male volunteers over 24 hours following oral administration. DPH plasma concentrations rose to peak levels in 1.5-2.5 hours varying with dose, declining to a nearly constant level by 12-24 hours. For all behavioral measures, the shape of performance curves over time was similar to that of plasma, reaching maximum decrements in 1-4 hours. The relation between plasma levels and performance was asynchronous varying with behavioral measure and dose. The use of plasma DPH values to predict performance decrements is limited due to the bivalued nature of these relationships in time. Nonetheless, it would appear that if DPH is administered in the therapeutic dosage range at the intervals typically recommended for cold symptoms and allergies, it appears some aspects of human performance may be impaired.

References

Apr 1, 1978·Clinical Pharmacology and Therapeutics·S G CarruthersD L Azarnoff
Jun 1, 1975·Journal of Pharmacokinetics and Biopharmaceutics·K S AlbertJ G Wagner
Jan 1, 1985·Psychopharmacology·G BarnettT Thompson
Oct 1, 1985·Journal of Psychoactive Drugs·S Krippner
Jan 1, 1983·Pharmacology, Biochemistry, and Behavior·C L RandallR F Anton
Apr 1, 1980·European Journal of Clinical Pharmacology·M Burns, H Moskowitz

❮ Previous
Next ❯

Citations

Dec 3, 2014·Psychiatry Research·Daniël KleinloogJoop van Gerven

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.